neurology

nusinersen therapy for pediatric spinal muscular atrophy

by Nivil Gopi - November 10, 2022November 25, 2022 01997

nusinersen therapy for pediatric spinal muscular atrophy Study Background Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by the degeneration of anterior horn cells of the spinal cord and brainstem. SMA primarily affects babies and young children and has an incidence of 1:10,000. It is caused by a homozygous

Stroke in the Presence of Renal Disease

by Armela Escalona - March 15, 2021April 27, 2021 03598

Stroke in the Presence of Renal Disease Stroke is a life-threatening medical condition that occurs when blood supply to the part of the brain is cut off. It is one of the leading causes of death and disability around the world. Most strokes are caused by blockage of arteries to the

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease?

by Armela Escalona - March 8, 2021April 27, 2021 06553

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease Cardiovascular diseases, including stroke, are major healthcare issues affecting humans worldwide. Between 2010 and 2030, the estimated total medical costs might escalate to from $273–$818 billion in the United States alone. Modifiable risk factors for stroke include hypertension, diabetes,